Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: Secretory leukocyte proteinase inhibitor and lysozyme

Infection and Immunity

Volumn 70, Issue 9, 2002, Pages 4908-4916

  Fernie King, Barbara A ^a   Seilly, David J ^a   Davies, Alexandra ^a   Lachmann, Peter J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LYSOZYME; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; STREPTOCOCCAL INHIBITOR OF COMPLEMENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; ENTHALPY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE SYSTEM; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; TEMPERATURE DEPENDENCE;

ANIMALS; BACTERIAL PROTEINS; CHICKENS; COMPLEMENT INACTIVATOR PROTEINS; ENZYME INHIBITORS; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; LACTOFERRIN; MURAMIDASE; PROTEIN BINDING; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RECOMBINANT PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; STREPTOCOCCUS PYOGENES; THERMODYNAMICS;

EID: 0036716438     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.9.4908-4916.2002     Document Type: Article

References (31)

1. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function
2. Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms
3. Selection of group A streptococci rich in M-protein from populations poor in M-protein
4. Identification of the bactericidal domain of lactoferrin
5. Enhancement of growth of aerobic, anaerobic, and facultative bacteria in mixed infections with anaerobic and facultative gram-positive cocci
6. Bacteriology of adenoids and tonsils in children with recurrent adenotonsillitis
7. Innate antimicrobial activity of nasal secretions
8. eNap-2, a novel cysteine-rich bactericidal peptide from equine leukocytes
9. Pathogenesis of group A streptococcal infections
10. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor
11. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes
12. Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysozomal enzymes
13. The 2.5 Å X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine α-chymotrypsin
14. Antibacterial activity of antileukoprotease
15. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics
16. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infections
17. Vertebrate lysozymes
18. Protein measurement with the folin phenol reagent
19. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization
20. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro
21. Adaptive evolution of highly mutable loci in pathogenic bacteria
22. The acidstable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor
23. Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens
24. Synergistic and additive killing by anti microbial factors found in human airway surface liquid
25. Remarkable attachment of lactoferrin to Streptococcus pyogenes during acute pharyngotonsillitis
26. Antileukoprotease: An endogenous protein in the innate mucosal defense against fungi
27. Antimicrobial peptides and proteins in the innate defence of the airway surface
28. Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement
29. Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes
30. Molecular cloning of human plasma membrane phospholipid scramblase